首页> 外文期刊>Global Journal of Surgery >Anaemia in Surgical Sepsis and Stress: The Roles of Erythropoietin, Iron and Steroids
【24h】

Anaemia in Surgical Sepsis and Stress: The Roles of Erythropoietin, Iron and Steroids

机译:贫血在外科败血症和压力中:促红细胞生成素,铁和类固醇的作用

获取原文
       

摘要

Background: Inflammation in surgical sepsis and stress frequently causes anaemia, leading to increased rates of blood transfusions. Recent evidence shows that blood transfusions carry a greater risk for short- and long-term complications than previously thought. Objective: To review the role of erythropoietin (EPO), iron and/or steroids as an alternative treatment to blood transfusions in critically ill patients. Methodology: A systematic review was prepared from recent literature on inflammation-induced anaemia, anaemia in the critically ill and/or septic patient and the roles of EPO, iron and corticosteroids in these patients. A meta-analysis was completed for EPO. Results: Inflammatory cytokines alter haematopoietic and biochemical pathways, leading to anaemia. Inflammation decreases circulating EPO and upregulates hepcidin, resulting in decreased free iron. Twelve randomised-controlled trials demonstrate that EPO administration in critically ill patients reduces the need for blood transfusions by 31% (p=0.005) however does not significantly decrease mortality (p=0.15). Intravenous iron also reduces the need for blood transfusions but has not been utilised in sepsis-associated anaemia. No trials focusing on the effects of steroids on sepsis-associated anaemia were identified. Conclusion: Due to the lack of data specific to sepsis-associated anaemia in post-operative patients, the roles of EPO, iron and steroids remain under investigation. More research specific to surgical patients is needed.
机译:背景:外科败血症和压力引起的炎症经常引起贫血,导致输血率增加。最近的证据表明,输血带来的短期和长期并发症的风险要比以前想象的要大。目的:探讨促红细胞生成素(EPO),铁和/或类固醇作为危重患者输血替代治疗的作用。方法:从近期文献中对危重症和/或败血症患者的炎症性贫血,贫血以及这些患者中EPO,铁和皮质类固醇的作用进行了系统的综述。对EPO进行了荟萃分析。结果:炎性细胞因子改变了造血和生化途径,导致贫血。炎症会降低循环EPO并上调铁调素,导致游离铁减少。十二项随机对照试验表明,重症患者服用EPO可使输血需求减少31%(p = 0.005),但并未显着降低死亡率(p = 0.15)。静脉铁还减少了输血的需要,但尚未用于败血症相关的贫血中。尚未找到侧重于类固醇对败血症相关性贫血影响的试验。结论:由于缺乏患者败血症相关性贫血的具体数据,EPO,铁和类固醇的作用仍在研究中。需要针对外科患者的更多研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号